Zevra Therapeutics, Inc.
ZVRA
$7.94
$0.020.25%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/14/2025
-
MarketBeat
3/14/2025
-
Ticker Report
3/13/2025
-
MarketBeat
3/13/2025
-
The Fly
3/13/2025
-
The Fly
3/13/2025
-
Tickeron - Stocks
3/13/2025
-
TipRanks Financial Blog
3/12/2025
-
MarketBeat
3/12/2025
-
The Fly
3/12/2025
-
MarketBeat
3/12/2025
-
GuruFocus
3/12/2025
-
GuruFocus
3/12/2025
-
TipRanks Financial Blog
3/12/2025
-
Seeking Alpha: Transcripts
3/12/2025
-
SeekingAlpha
3/11/2025
-
Zacks Investment Research
3/11/2025
-
SeekingAlpha.com: All News
3/11/2025
-
The Fly
3/11/2025
-
Globe Newswire
3/10/2025
-
Simply Wall St
3/7/2025
-
Tickeron - Technical Analysis
3/7/2025
-
Tickeron - Stocks
3/6/2025
-
Tickeron - Stocks
3/6/2025
-
Tickeron - Stocks
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Wednesday, March 12, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
321 939 3416
Address
1180 Celebration Boulevard
Celebration, FL 34747
Celebration, FL 34747
Country
Year Founded
Business Description
Sector
Zevra Therapeutics, Inc. discovers and develops various proprietary prodrugs to treat serious medical conditions in the United States. The company develops its products through Ligand Activated...
more
